Human equilibrative nucleoside transporter‐1 and deoxycytidine kinase can predict gemcitabine effectiveness in Egyptian patients with Hepatocellular carcinoma

BACKGROUND: Several biomarkers of gemcitabine effectiveness have been studied in cancers, but less so in hepatocellular carcinoma (HCC), which is identified as the fifth most common cancer worldwide. Investigation of human equilibrative nucleoside transporter‐1 (HENT‐1) and deoxycytidine kinase (DCK...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Fadia, Fathy, Sara, Anani, Maha, Hassan, Adel, Attia, Fawzy, Ibrahim, Gehan, Elazab, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676182/
https://www.ncbi.nlm.nih.gov/pubmed/32671914
http://dx.doi.org/10.1002/jcla.23457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676182/
https://www.ncbi.nlm.nih.gov/pubmed/32671914
http://dx.doi.org/10.1002/jcla.23457

Ejemplares similares